SSS

SPAGO NANOMEDICAL AB

No trades
See on Supercharts
Market capitalization
‪80.45 M‬SEK
−0.388SEK
‪−42.22 M‬SEK
‪1.20 M‬SEK
Beta (1Y)
1.59

About SPAGO NANOMEDICAL AB

CEO
Mats Hansen
Headquarters
Lund
Founded
1999
FIGI
BBG003Q0FJC3
Spagpo Nanomedical AB engages in the provision of research and development within nanomedicine. The firm focuses on the development of nanomaterials for tumor diagnostics and treatment of cancer. Its projects include SpagoPix and Tumorad. The company was founded IN 2007 and is headquartered in Lund, Sweden.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of SPAGO is 0.360 SEK — it has increased by 0.56% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange SPAGO NANOMEDICAL AB stocks are traded under the ticker SPAGO.
SPAGO stock is 14.15% volatile and has beta coefficient of 1.59. Check out the list of the most volatile stocks — is SPAGO NANOMEDICAL AB there?
SPAGO NANOMEDICAL AB revenue for the last quarter amounts to ‪300.00 K‬ SEK despite the estimated figure of ‪2.50 M‬ SEK. In the next quarter revenue is expected to reach ‪500.00 K‬ SEK.
Yes, you can track SPAGO NANOMEDICAL AB financials in yearly and quarterly reports right on TradingView.
SPAGO stock has risen by 7.46% compared to the previous week, the month change is a 35.34% rise, over the last year SPAGO NANOMEDICAL AB has showed a 51.48% decrease.
SPAGO net income for the last quarter is ‪−9.42 M‬ SEK, while the quarter before that showed ‪−7.11 M‬ SEK of net income which accounts for −32.39% change. Track more SPAGO NANOMEDICAL AB financial stats to get the full picture.
Today SPAGO NANOMEDICAL AB has the market capitalization of ‪80.90 M‬, it has increased by 0.66% over the last week.
No, SPAGO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, SPAGO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SPAGO NANOMEDICAL AB stock right from TradingView charts — choose your broker and connect to your account.
SPAGO reached its all-time high on Mar 26, 2021 with the price of 8.878 SEK, and its all-time low was 0.200 SEK and was reached on Nov 9, 2023.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SPAGO NANOMEDICAL AB technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SPAGO NANOMEDICAL AB stock shows the neutral signal. See more of SPAGO NANOMEDICAL AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on SPAGO NANOMEDICAL AB future price: according to them, SPAGO price has a max estimate of 1.00 SEK and a min estimate of 1.00 SEK. Read a more detailed SPAGO NANOMEDICAL AB forecast: see what analysts think of SPAGO NANOMEDICAL AB and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SPAGO NANOMEDICAL AB EBITDA is ‪−43.51 M‬ SEK, and current EBITDA margin is ‪−3.90 K‬%. See more stats in SPAGO NANOMEDICAL AB financial statements.